Akido Labs
Healthcare technology
AI-enabled care delivery and clinical AI
Series B
Akido Labs is a Los Angeles-based healthcare technology and care-delivery company that combines AI tools with a clinician-supervised provider network. Its ScopeAI platform is intended to support clinical workflows and care delivery, while Akido operates primary and specialty care services, including in safety-net settings. The company describes its approach as building an AI-native health system; its network has been reported across California, Rhode Island, and New York. These are company-reported positioning and operating details, not independent evidence of clinical outcomes or market leadership.
Company Details
- Website
- akidolabs.com
- Headquarters
- Los Angeles, California
- Founded
- 2015
- Funding
- $60 million announced in a Series B in May 2025. Public funding databases report differing cumulativ
Subscriber Intelligence
- • Deal signal alerts for this company
- • Sentiment & risk scoring
- • Competitive framework analysis
- • Regulatory event monitoring